Simultaneous Bilateral Upper Extremity Venous Thrombosis in a Factor V Leiden Heterozygote: A Case Report and Review

Vascular and Endovascular Surgery

Volumn 35, Issue 5, 2001, Pages 361-368

  Sullivan, Vita V ^a   Wolk, Seth W ^a   Whitehouse, Walter M ^b  

^a St Joseph Mercy Hospital ^*

^b ST JOSEPH MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANGIOPLASTY; ARTICLE; AXILLARY VEIN; CASE REPORT; CLINICAL EXAMINATION; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; FIBRINOLYTIC THERAPY; HETEROZYGOTE; HUMAN; HYPERCOAGULABILITY; MALE; PHLEBOGRAPHY; SUBCLAVIAN VEIN; VEIN RECONSTRUCTION;

ADULT; ARM; AXILLARY VEIN; FACTOR V; HETEROZYGOTE; HUMANS; MALE; SUBCLAVIAN VEIN; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOSIS;

EID: 0034815608     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857440103500506     Document Type: Review

References (20)

1. Azakie A, McElhinney DB, Thompson RW, et al: Surgical management of subclavian-vein effort thrombosis as a result of thoracic outlet compression. J Vasc Surg 28: 777-786, 1998.
2. Machleder HI: Effort thrombosis of the axillosubclavian vein: A disabling vascular disorder. Compr Ther 17: 18-24, 1991.
3. Haire WD: Arm vein thrombosis. Clin Chest Med 16: 341-351, 1995.
4. Adelman MA, Stone DH, Riles TS, et al: A multidisciplinary approach to the treatment of Paget-Schroetter syndrome. Ann Vasc Surg 11: 149-154, 1997.
5. Gloviczki P, Kazmier FJ, Hollier LH: Axillary-subclavian venous occlusion: The morbidity of a nonlethal disease. J Vasc Surg 4: 333-337, 1986.
6. Lee MC, Grassi CJ, Belkin M, et al: Early operative intervention after thrombolytic therapy for primary subclavian vein thrombosis: An effective treatment approach. J Vasc Surg 27: 1101-1107,; discussion 1107-1108 1998.
7. Urschel HC Jr, Razzuk MA: Improved management of the Paget-Schroetter syndrome secondary to thoracic outlet compression. Ann Thorac Surg 52: 1217-1221, 1991.
8. Machleder HI: Evaluation of a new treatment strategy for Paget-Schroetter syndrome: Spontaneous thrombosis of the axillary-subclavian vein. J Vasc Surg 17: 305-315,; discussion 316-317 1993.
9. Druy EM, Trout HH, Giordano JM, et al: Lytic therapy in the treatment of axillary and subclavian vein thrombosis. J Vasc Surg 2: 821-827, 1985.
10. Lee WA, Hill BB, Harris EJ Jr, et al: Surgical intervention is not required for all patients with subclavian vein thrombosis. J Vasc Surg 32: 57-67, 2000.
11. Bertina RM: Molecular risk factors for thrombosis. Thromb Haemost 82: 601-609, 1999.
12. Rosendaal FR: Risk factors for venous thrombotic disease. Thromb Haemost 82: 610-619, 1999.
13. Hingorani A, Ascher E, Yorkovich W, et al: Upper extremity deep venous thrombosis: An underrecognized manifestation of a hypercoagulable state [in process citation]. Ann Vasc Surg 14: 421-426, 2000.
14. Koster T, Rosendaal FR, de Ronde H, et al: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study [see comments]. Lancet 342: 1503-1506, 1993.
15. Bick RL, Kaplan H: Syndromes of thrombosis and hypercoagulability. Congenital and acquired causes of thrombosis. Med Clin North Am 82: 409-458, 1998.
16. Dahlback B: Activated protein C resistance and thrombosis: Molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Hemost 25: 273-289, 1999.
17. Engel H, Zwang L, van Vliet HH, et al: Phenotyping and genotyping of coagulation factor V Leiden. Thromb Haemost 75: 267-269, 1996.
18. Dahlback B: Resistance to activate protein C, the Arg5O6 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons [see comments]. Thromb Haemost 73: 739-742, 1995.
19. Alving B: Update on recognition and management of patients with acquired or inherited hypercoagulability. Compr Ther 24: 302-309, 1998.
20. Green RM, Waldman D, Ouriel K, et al: Claviculectomy for subclavian venous repair: Long-term functional results. J Vasc Surg 32: 315-321, 2000.